Neurovance Australia Pty Ltd

Status: Registered

Australian Company Number: 160851052

Australian Business Number: 70160851052

Registration date: October 19, 2012

Type: Australian proprietary company

Class: Limited by Shares

Subclass: Proprietary other

last updated 24.10.2023

Description

Neurovance Australia Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2012-10-19 and was issued with the 160851052 ACN. Its Australian Business Number is 70160851052. Since 2012-11-07, the company is headquartered in VIC, post code 3006. The previous headquarters were located in VIC 3006 (from 2012-10-19 to 2012-11-07). Neurovance Australia Pty Ltd was registered for the GST on 2012-10-19. The above data comes from the ABN database which was updated on 2013-08-16.

Details for ABN 70160851052

Type: Australian Private Company

ABN Status

Status	From	To
Active	October 19, 2012	current

Main Name

Name	From	To
Neurovance Australia Pty Ltd	October 19, 2012	current

Main Location

Location	From	To
VIC 3006	November 7, 2012	current
VIC 3006	October 19, 2012	November 7, 2012

Goods & Services Tax (GST)

Status	From	To
Registered	October 19, 2012	current

Company Patents

Patent Application Number: 2006275870

General information:

Application date:	February 26, 2008
Patent status:	Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.
Patent type:	NPE
Primary IPC mark:	A61K 31/40
WIPO Application Number:	WO2007/016155
Original WIPO Application Number:	WO07/16155
PCT Application Number:	PCT/US2006/029006
Original PCT Application Number:	PCT/US06/29006
Accepted claims count:	48

International Patent Classification:

IPC Mark:	A61K 31/40
Version date of the IPC Classification record:	January 1, 2006
Section code:	A - human necessities
Class code:	61 - medical or veterinary science; hygiene
Subclass code:	K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l)
Main group code:	31 - medicinal preparations containing organic active ingredients
Subgroup code:	40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Mark type:	First (ie Primary)
Classification level:	Advanced
Classification code:	Inventive
IPC Classification assigned/Application publish date:	November 15, 2007
Classification type code:	Original
Classification source code:	Human

IP Australia process information:

Source code:	PAMS
Patent classification type:	Standard
Examination request date:	November 10, 2009
Examination request filing date:	April 27, 2010
Requested examination type:	Request Full Examination
First report issue date:	March 10, 2011
Examination section:	C2 Chemistry
Expiry date:	July 25, 2026
Earliest priority date:	July 27, 2005
Acceptance Notice date:	January 10, 2013
Sealing date:	May 2, 2013
WIPO publication date:	February 8, 2007
Effective patent date:	July 25, 2006
Continue renew fee paid date:	June 23, 2014
Patent in force to:	July 25, 2015

Change of Ownership:

Request filed date:	August 2, 2013
Name change date:	August 23, 2013
Advertised date:	September 5, 2013
Change reason:	Request for Assignment
Assignment validated date:	July 20, 2010
Document description:	Certificate of Merger
Name type:	New